Evaluation of Safe Systemic Immunosuppression Created with Dexamethasone in Prevention of Capsular Contracture: A Glance to Distinct Perspectives with Toll-Like Receptors

dc.authoridOzer, Kadri/0000-0003-2966-6618
dc.authoridDikmen, Adile/0000-0002-5601-1847
dc.authoridOzakinci, Hilal/0000-0001-7921-1000
dc.contributor.authorColak, Ozlem
dc.contributor.authorOzer, Kadri
dc.contributor.authorDikmen, Adile
dc.contributor.authorOzakinci, Hilal
dc.contributor.authorOzkaya, Ozay
dc.date.accessioned2025-03-23T19:44:38Z
dc.date.available2025-03-23T19:44:38Z
dc.date.issued2018
dc.departmentSinop Üniversitesi
dc.description.abstractPurpose The toll-like receptors (TLRs) stand at the interface of innate immune activation. We hypothesize to decrease the response of innate immunity activated by TLR4 by a safe, short-term, systemic immunosuppression. Methods Two silicone block implants were placed into two dorsal subcutaneous pockets in 32 rats that were subdivided into four groups: The two study groups were the IV DEX group (single intravenous injection of dexamethasone 1 h before surgery) and the IV DEX + IP DEX group (in addition to a single intravenous injection of dexamethasone 1 h before surgery, intraperitoneal dexamethasone was administered for 10 days after surgery), and the two control groups were the untreated control group and the saline-treated control group. After 10 weeks, all animals were killed to determine capsular thickness, inflammatory cell density, presence of pseudoepitheliomatous hyperplasia, edema, necrosis, vascularization, TLR4 expression and myofibroblast proliferation. Results No significant difference was observed in any parameter between the untreated and saline-treated control groups (p > 0.05). Capsular thickness, myofibroblast proliferation, TLR4 expression density were statistically different among study groups compared to control (p < 0.05). Conclusions This study demonstrates the relationship between toll-like receptors and fibrous capsule after implant surgery. Decreasing the innate immunity by a safe, short-term perioperative systemic immunosuppression resulted in decreased TLR4 expression and myofibroblast differentiation which could be a new research field in profibrotic pathophysiology underlying breast capsule formation. No Level Assigned This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
dc.identifier.doi10.1007/s00266-018-1119-9
dc.identifier.endpage1143
dc.identifier.issn0364-216X
dc.identifier.issn1432-5241
dc.identifier.issue4
dc.identifier.pmid29564486
dc.identifier.scopusqualityQ1
dc.identifier.startpage1133
dc.identifier.urihttps://doi.org/10.1007/s00266-018-1119-9
dc.identifier.urihttps://hdl.handle.net/11486/6986
dc.identifier.volume42
dc.identifier.wosWOS:000440395700028
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofAesthetic Plastic Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250323
dc.subjectCapsule formation
dc.subjectDexamethasone
dc.subjectToll-like receptor
dc.subjectImplant
dc.titleEvaluation of Safe Systemic Immunosuppression Created with Dexamethasone in Prevention of Capsular Contracture: A Glance to Distinct Perspectives with Toll-Like Receptors
dc.typeArticle

Dosyalar